Fibrosing mediastinitis: Clinical presentation, therapeutic outcomes, and adaptive immune response

Medicine

Volumn 90, Issue 6, 2011, Pages 412-423

  Peikert, Tobias ^a   Colby, Thomas V ^d   Midthun, David E ^a   Pairolero, Peter C ^b   Edell, Eric S ^a   Schroeder, Darrell R ^c   Specks, Ulrich ^a  

^a Mayo Clinic   (United States)

^b Division of General Thoracic Surgery   (United States)

^c MAYO CLINIC   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; ITRACONAZOLE; PREDNISONE; TAMOXIFEN;

ADAPTIVE IMMUNITY; ADULT; AGED; BALLOON DILATATION; BIOPSY; CLINICAL FEATURE; CYTOREDUCTIVE SURGERY; DECOMPRESSION SURGERY; FEMALE; HISTOPLASMOSIS; HUMAN; HUMAN TISSUE; LOBECTOMY; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; OVERALL SURVIVAL; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PULMONARY ARTERY BALLOON ANGIOPLASTY; PULMONARY VEIN BALLOON ANGIOPLASTY; REVIEW; STENT; TREATMENT OUTCOME; TREATMENT RESPONSE; VEIN GRAFT;

ADAPTIVE IMMUNITY; ADULT; AGED; FEMALE; FIBROSIS; HUMANS; MALE; MEDIASTINITIS; MEDIASTINUM; MIDDLE AGED; RADIOGRAPHY, THORACIC; YOUNG ADULT;

EID: 80755140613     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e318237c8e6     Document Type: Review

References (41)

1. Brown ML, Cedeno AR, Edell ES, Hagler DJ, Schaff HV. Operative strategies for pulmonary artery occlusion secondary to mediastinal fibrosis. Ann Thorac Surg. 2009;88:233-237.
2. Chong S, Kim TS, Kim BT, Cho EY. Fibrosing mediastinitis mimicking malignancy at CT: negative FDG uptake in integrated FDG PET/CT imaging. Eur Radiol. 2007;17:1644-1646. (Pubitemid 46767613)
3. Davis AM, Pierson RN, Loyd JE. Mediastinal fibrosis. Semin Respir Infect. 2001;16:119-130. (Pubitemid 32606849)
4. Dines DE, Payne WS, Bernatz PE, Pairolero PC. Mediastinal granuloma and fibrosing mediastinitis. Chest. 1979;75:320-324. (Pubitemid 9142554)
5. Dodds GA III, Harrison JK, O'Laughlin MP, Wilson JS, Kisslo KB, Bashore TM. Relief of superior vena cava syndrome due to fibrosing mediastinitis using the Palmaz stent. Chest. 1994;106:315-318. (Pubitemid 24214785)
6. Doyle TP, Loyd JE, Robbins IM. Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis. Am J Respir Crit Care Med. 2001;164:657-660. (Pubitemid 32801673)
7. Dunn EJ, Ulicny KS Jr, Wright CB, Gottesman L. Surgical implications of sclerosing mediastinitis. A report of six cases and review of the literature. Chest. 1990;97:338-346. (Pubitemid 20050670)
8. Ferguson ME, Cabalka AK, Cetta F, Hagler DJ. Results of intravascular stent placement for fibrosing mediastinitis. Congenit Heart Dis. 2010;5:124-133.
9. Flieder DB, Suster S, Moran CA. Idiopathic fibroinflammatory (fibrosing/sclerosing) lesions of the mediastinum: a study of 30 cases with emphasis on morphologic heterogeneity. Mod Pathol. 1999;12:257-264. (Pubitemid 29133846)
10. Garrett HE Jr, Roper CL. Surgical intervention in histoplasmosis. Ann Thorac Surg. 1986;42:711-722. (Pubitemid 17195043)
11. Goodwin RA, Nickell JA, Des Prez RM. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine (Baltimore). 1972;51:227-246.
12. Graham JR, Suby HI, LeCompte PR, Sadowsky NL. Fibrotic disorders associated with methysergide therapy for headache. N Engl J Med. 1966;274:359-368.
13. Guerrero A, Hoffer EK, Hudson L, Schuler P, Karmy-Jones R. Treatment of pulmonary artery compression due to fibrous mediastinitis with endovascular stent placement. Chest. 2001;119:966-968. (Pubitemid 32197675)
14. Hammoud ZT, Rose AS, Hage CA, Knox KS, Rieger K, Kesler KA. Surgical management of pulmonary and mediastinal sequelae of histoplasmosis: a challenging spectrum. Ann Thorac Surg. 2009;88:399-403.
15. Ichimura H, Ishikawa S, Yamamoto T, Onizuka M, Inadome Y, Noguchi M, Sakakibara Y. Effectiveness of steroid treatment for hoarseness caused by idiopathic fibrosing mediastinitis: report of a case. Surg Today. 2006;36:382-384.
16. Ikeda K, Nomori H, Mori T, Kobayashi H, Iwatani K, Yoshimoto K, Yoshioka M. Successful steroid treatment for fibrosing mediastinitis and sclerosing cervicitis. Ann Thorac Surg. 2007;83:1199-1201. (Pubitemid 46328801)
17. Inoue M, Nose N, Nishikawa H, Takahashi M, Zen Y, Kawaguchi M. Successful treatment of sclerosing mediastinitis with a high serum IgG4 level. Gen Thorac Cardiovasc Surg. 2007;55:431-433. (Pubitemid 47561738)
18. Kandzari DE, Warner JJ, O'Laughlin MP, Harrison JK. Percutaneous stenting of right pulmonary artery stenosis in fibrosing mediastinitis. Catheter Cardiovasc Interv. 2000;49:321-324. (Pubitemid 30133526)
19. Katzenstein AA, Askin FB, Livolsi VA. Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease. 3rd ed. Philadelephia: WB Saunders; 1997.
20. Lafyatis R, Kissin E, York M, Farina G, Viger K, Fritzler MJ, Merkel PA, Simms RW. B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum. 2009;60:578-583.
21. Lal C, Weiman D, Eltorky M, Pugazhenthi M. Complete resolution of fibrosing mediastinitis with corticosteroid therapy. South Med J. 2005;98:749-750. (Pubitemid 41061667)
22. Lee KY, Yi JG, Park JH, Kim YJ, So Y, Kim JS. Fibrosing mediastinitis manifesting as thoracic prevertebral thin band-like mass on MRI and PET-CT. Br J Radiol. 2007;80:e141Ye144.
23. Loyd JE, Tillman BF, Atkinson JB, Des Prez RM. Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore). 1988;67:295-310.
24. Mathisen DJ, Grillo HC. Clinical manifestation of mediastinal fibrosis and histoplasmosis. Ann Thorac Surg. 1992;54:1053-1057.
25. McGonagle D, Tan AL, Madden J, Rawstron AC, Rehman A, Emery P, Thomas S. Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab. Rheumatology (Oxford). 2008;47:552-553.
26. Mole TM, Glover J, Sheppard MN. Sclerosing mediastinitis: a report on 18 cases. Thorax. 1995;50:280-283.
27. Peebles RS, Carpenter CT, Dupont WD, Loyd JE. Mediastinal fibrosis is associated with human leukocyte antigen-A2. Chest. 2000;117:482-485. (Pubitemid 30111602)
28. Peikert T, Goetze S, Ghaffari S. A rare cause of coronary obstruction and angina pectoris. Heart. 2003;89:1120.
29. Rossi SE, McAdams HP, Rosado-de-Christenson ML, Franks TJ, Galvin JR. Fibrosing mediastinitis. Radiographics. 2001;21:737-757.
30. Satpathy R, Aguila V, Mohiuddin SM, Khan IA. Fibrosing mediastinitis presenting as pulmonary stenosis: stenting works. Int J Cardiol. 2007;118:e85Ye86. (Pubitemid 46678260)
31. Savelli BA, Parshley M, Morganroth ML. Successful treatment of sclerosing cervicitis and fibrosing mediastinitis with tamoxifen. Chest. 1997;111:1137-1140. (Pubitemid 27171497)
32. Schowengerdt CG, Suyemoto R, Main FB. Granulomatous and fibrous mediastinitis. A review and analysis of 180 cases. J Thorac Cardiovasc Surg. 1969;57:365-379.
33. Sherrick AD, Brown LR, Harms GF, Myers JL. The radiographic findings of fibrosing mediastinitis. Chest. 1994;106:484-489. (Pubitemid 24252047)
34. Smith SJ, Vyborny CJ, Hines JL. Re: chronic superior vena cava occlusion related to fibrosing mediastinitis treated with self-expanding shunts. Cardiovasc Intervent Radiol. 1997;20:161-162. (Pubitemid 27131356)
35. Straus SE, Jacobson ES. The spectrum of histoplasmosis in a general hospital: a review of 55 cases diagnosed at Barnes Hospital between 1966 and 1977. Am J Med Sci. 1980;279:147-158. (Pubitemid 10039615)
36. Strimlan CV, Dines DE, Payne WS. Mediastinal granuloma. Mayo Clin Proc. 1975;50:702-705.
37. Takalkar AM, Bruno GL, Makanjoula AJ, El-Haddad G, Lilien DL, Payne DK. A potential role for F-18 FDG PET/CT in evaluation and management of fibrosing mediastinitis. Clin Nucl Med. 2007;32:703-706. (Pubitemid 47294865)
38. Thiessen R, Matzinger FR, Seely J, Aina R, Macleod P. Fibrosing mediastinitis: successful stenting of the pulmonary artery. Can Respir J. 2008;15:41-44. (Pubitemid 351566064)
39. Urschel HC Jr, Razzuk MA, Netto GJ, Disiere J, Chung SY. Sclerosing mediastinitis: improved management with histoplasmosis titer and ketoconazole. Ann Thorac Surg. 1990;50:215-221. (Pubitemid 20255942)
40. Wheat LJ, Slama TG, Eitzen HE, Kohler RB, French ML, Biesecker JL. A large urban outbreak of histoplasmosis: clinical features. Ann Intern Med. 1981;94:331-337. (Pubitemid 11137072)
41. Yoshizaki A, Iwata Y, Komura K, Ogawa F, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Tedder TF, Sato S. CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol. 2008;172:1650-1663. (Pubitemid 351793356)